Radioimmunotherapy for B-Cell Lymphoma: Y90 Ibritumomab Tiuxetan and I131 Tositumomab

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210378
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network

Bone Marrow Transplantation
TransplantationHematology
2010English

90 Y-Ibritumomab Tiuxetan in Patients With Extra-Nodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (Malt Lymphoma) - The Zeno Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Assessment of Treatment-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia in Patients With Non-Hodgkin Lymphoma Treated With Tositumomab and Iodine I131 Tositumomab

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

Clinical Cancer Research
Cancer ResearchOncology
2007English

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (With Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

131-Iodine Tositumomab in Lymphoma

Current Oncology
Oncology
2009English

CONSOLIDATION THERAPY USING 90 Y-Ibritumomab TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- And 90y-Ibritumomab Tiuxetan

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

A New Pharmacokinetic Model for 90y-Ibritumomab Tiuxetan Based on 3-Dimensional Dosimetry

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy